| Description of the updated nutrition calculation of the Oxford WebQ questionnaire and comparison with the previous version among 207,144 participants in UK Biobank A Perez-Cornago, Z Pollard, H Young, M van Uden, C Andrews, ... European journal of nutrition 60 (7), 4019-4030, 2021 | 155 | 2021 |
| Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform L Nab, EPK Parker, CD Andrews, WJ Hulme, L Fisher, J Morley, ... The Lancet public health 8 (5), e364-e377, 2023 | 63 | 2023 |
| OpenSAFELY: Representativeness of electronic health record platform OpenSAFELY-TPP data compared to the population of England C Andrews, A Schultze, H Curtis, W Hulme, J Tazare, S Evans, A Mehrkar, ... Wellcome Open Research 7, 2022 | 57 | 2022 |
| Long-term efficacy and tolerability of TNFα inhibitors in the treatment of non-infectious ocular inflammation: an 8-year prospective surveillance study SM Sharma, E Damato, AE Hinchcliffe, CD Andrews, K Myint, R Lee, ... British Journal of Ophthalmology 105 (9), 1256-1262, 2021 | 52 | 2021 |
| Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian … EL Watts, A Perez-Cornago, GK Fensom, K Smith-Byrne, U Noor, ... International journal of epidemiology 52 (1), 71-86, 2023 | 42 | 2023 |
| Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia EL Watts, A Perez‐Cornago, GK Fensom, K Smith‐Byrne, U Noor, ... International journal of cancer 151 (7), 1033-1046, 2022 | 41 | 2022 |
| Impaired dark adaptation associated with a diseased Bruch membrane in pseudoxanthoma elasticum K Hess, M Gliem, J Birtel, P Müller, D Hendig, C Andrews, IJ Murray, ... Retina 40 (10), 1988-1995, 2020 | 33 | 2020 |
| Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY OpenSAFELY Collaborative, A Green, H Curtis, W Hulme, E Williamson, ... BMC medicine 20 (1), 243, 2022 | 31 | 2022 |
| Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP WJ Hulme, EMF Horne, EPK Parker, RH Keogh, EJ Williamson, V Walker, ... bmj 380, 2023 | 30 | 2023 |
| Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT) O Carlile, A Briggs, AD Henderson, BFC Butler-Cole, J Tazare, ... The Lancet Regional Health–Europe 40, 2024 | 26 | 2024 |
| Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective … ACA Green, HJ Curtis, R Higgins, L Nab, V Mahalingasivam, RM Smith, ... BMJ medicine 2 (1), 2023 | 25* | 2023 |
| Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank A Perez-Cornago, GK Fensom, C Andrews, EL Watts, NE Allen, ... British Journal of Cancer 123 (12), 1808-1817, 2020 | 24 | 2020 |
| Sleep–wake disturbance related to ocular disease: a systematic review of phase-shifting pharmaceutical therapies CD Andrews, RG Foster, I Alexander, S Vasudevan, SM Downes, ... Translational Vision Science & Technology 8 (3), 49-49, 2019 | 18 | 2019 |
| Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY MD Russell, JB Galloway, CD Andrews, B MacKenna, B Goldacre, ... The Lancet Rheumatology 4 (12), e853-e863, 2022 | 17 | 2022 |
| Low-contrast visual acuity versus low-luminance visual acuity in choroideremia LJ Wood, JK Jolly, CD Andrews, IR Wilson, D Hickey, ... Clinical and Experimental Optometry 104 (1), 90-94, 2021 | 16 | 2021 |
| Changes in COVID-19-related mortality across key demographic and clinical subgroups: an observational cohort study using the OpenSAFELY platform on 18 million adults in England OpenSAFELY Collaborative, L Nab, EPK Parker, CD Andrews, WJ Hulme, ... medRxiv, 2022.07. 30.22278161, 2022 | 11 | 2022 |
| COVID-19 and mental illnesses in vaccinated and unvaccinated people VM Walker, P Patalay, JIC Coronado, R Denholm, H Forbes, J Stafford, ... JAMA psychiatry 81 (11), 1071-1080, 2024 | 9 | 2024 |
| Clinical coding of long COVID in primary care 2020–2023 in a cohort of 19 million adults: an OpenSAFELY analysis AD Henderson, BFC Butler-Cole, J Tazare, LA Tomlinson, M Marks, M Jit, ... Eclinicalmedicine 72, 2024 | 9 | 2024 |
| Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: a … O Macdonald, A Green, A Walker, H Curtis, R Croker, A Brown, ... BMJ Ment Health 26 (1), 2023 | 9 | 2023 |
| Gout incidence and management during the COVID-19 pandemic in England, UK: a nationwide observational study using OpenSAFELY MD Russell, J Massey, E Roddy, B MacKenna, S Bacon, B Goldacre, ... The Lancet Rheumatology 5 (10), e622-e632, 2023 | 8 | 2023 |
